ANEB
Anebulo Pharmaceuticals (ANEB)
$23
About Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
Details
Daily high
$2.30
Daily low
$2.16
Price at open
$2.16
52 Week High
$3.42
52 Week Low
$0.80
Market cap
91.6M
Dividend yield
0.00%
Volume
18,612
Avg. volume
16,893
P/E ratio
-9.47
Anebulo Pharmaceuticals News
Details
Daily high
$2.30
Daily low
$2.16
Price at open
$2.16
52 Week High
$3.42
52 Week Low
$0.80
Market cap
91.6M
Dividend yield
0.00%
Volume
18,612
Avg. volume
16,893
P/E ratio
-9.47